Announced Thu, 23 Apr, 2026 · 19:10 IST

Inventurus Knowledge Solutions Limited has informed the Exchange about Investor Presentation

Promoter Disclosed Acquisition PlansAnalyst Day Multiyear TargetsCfo Debt Reduction RoadmapMgmt Guided Margin ImprovementInvestor Communications View source PDFExplain this filing

IKS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+4.7%1-day move
₹1435.40
prior close
₹1476.90
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+2.0+5.3+5.2+3.2+4.7+6.2+8.8+15.0+16.9+16.2+11.0+14.9+19.8+23.0
Up moveDown movePending
AI summary

IKS Health has announced a definitive agreement to acquire 100% of TruBridge Inc. for an enterprise value of $557 million (equity $427M + debt $130M), taking the US-listed company private. The acquisition will be funded through approximately $600 million of debt at SOFR+275 bps. TruBridge is a fully integrated Revenue Cycle Management (RCM) and Electronic Health Record (EHR) vendor serving mid-small and rural hospitals, with $221M revenue, ~3,700 employees, and ~1,500 clients. Post-acquisition proforma combined revenue is $698M with adjusted EBITDA of $186M. The deal is expected to be PAT and EPS accretive in FY27 with incremental EBITDA adequate to cover interest and amortization costs. IKS targets FY2030 revenue of ~₹3,000 Crores and EBITDA of ~₹1,000 Crores, leveraging ~$575M cross-sell white space in TruBridge's client base.

Likely market impact

This acquisition significantly expands IKS Health's addressable market into rural hospital EHR and acute RCM, creating a combined entity with ~17,000 employees and 2,000+ clients. The deal is funded by debt at ~3X leverage, with management guiding margin improvement to 30%+ combined EBITDA within 4 quarters. Shareholders should monitor integration execution and debt servicing given the leveraged buyout structure.